GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 424 filers reported holding GLOBUS MED INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,428 | +195.1% | 492 | +254.0% | 0.00% | +100.0% |
| Q2 2023 | $8,277 | +5.1% | 139 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $7,873 | -53.7% | 139 | -39.3% | 0.00% | -50.0% |
| Q4 2022 | $17,008 | +30.8% | 229 | +9.0% | 0.00% | 0.0% |
| Q3 2022 | $13,000 | +225.0% | 210 | +195.8% | 0.00% | +100.0% |
| Q2 2022 | $4,000 | -20.0% | 71 | +10.9% | 0.00% | 0.0% |
| Q1 2022 | $5,000 | +25.0% | 64 | +28.0% | 0.00% | – |
| Q4 2021 | $4,000 | 0.0% | 50 | -7.4% | 0.00% | -100.0% |
| Q3 2021 | $4,000 | 0.0% | 54 | +12.5% | 0.00% | 0.0% |
| Q2 2021 | $4,000 | +100.0% | 48 | +65.5% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 29 | -3.3% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 30 | +36.4% | 0.00% | – |
| Q3 2020 | $1,000 | -66.7% | 22 | -61.4% | 0.00% | -100.0% |
| Q2 2020 | $3,000 | +200.0% | 57 | +159.1% | 0.00% | – |
| Q1 2020 | $1,000 | -97.4% | 22 | -97.6% | 0.00% | -100.0% |
| Q2 2019 | $38,000 | +65.2% | 904 | +88.7% | 0.01% | +50.0% |
| Q1 2019 | $23,000 | – | 479 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |